REVIEW
Published on 22 Jul 2026
Hypomethylating agents are the current therapy backbone for MDS and AML relapsing after allogeneic hematopoietic stem cell transplantation
doi 10.3389/fimmu.2026.1895791
- 792 views
- Frontiers in Immunology
- Alloimmunity and Transplantation
- Research Topics
- Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
1,477
Total downloads
11k
Total views and downloads
Articles
CASE REPORT
Published on 02 Jul 2026
Repeated courses of sequential venetoclax and donor lymphocyte infusions in a patient with relapsed high-risk myelodysplasia following allogeneic stem cell transplantation: a case report
doi 10.3389/fimmu.2026.1839984
- 1,569 views
CASE REPORT
Published on 26 May 2026
Case Report: donor cell-derived leukemia after allogeneic stem cell transplantation for metastatic renal cell carcinoma
doi 10.3389/fimmu.2026.1830323
- 1,641 views
BRIEF RESEARCH REPORT
Published on 19 May 2026
The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemia
doi 10.3389/fimmu.2026.1818603
- 1,607 views
REVIEW
Published on 07 Apr 2026
Immune monitoring for relapse of acute myeloid leukemia after allogeneic stem cell transplantation in clinical laboratories
doi 10.3389/fimmu.2026.1778853
- 2,785 views
- 1 citation
